Versão brasileira da Escala de Avaliação da Cognição em Esquizofrenia (SCoRS-Br): validação em contextos clínicos sem informantes

Ferreira, Breno de Castro; Barbosa, Marilourdes do Amaral; Barbosa, Izabela Guimarães; Borges, A. Larre; Hara, Cláudia; Rocha, Fábio Lopes

doi:10.1590/s0047-20852010000400002

Cited by 4 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cognitive performance was assessed by the Brazilian version of the Schizophrenia Cognition Rating Scale (SCoRS-BR) 16 . This is an interview-based scale that includes information provided by both the patient and an informant.…”

Section: Clinical Cognitive and Quality Of Life Assessmentsmentioning

confidence: 99%

Toxoplasma gondii infection and chronic schizophrenia: is there any association?

Campos-Carli

Vieira

Rocha

et al. 2017

Arch. Clin. Psychiatry (São Paulo)

Self Cite

View full text Add to dashboard Cite

Background: Toxoplasma gondii (T. gondii) infection has been identified as a risk factor for schizophrenia. Objectives: Herein, we sought to evaluate the association between T. gondii infection and clinical symptoms and quality of life in patients with schizophrenia. Methods: We conducted a cross-sectional study with 48 patients with chronic schizophrenia and 40 controls. Peripheral blood was drawn, and IgM and IgG anti-T. gondii antibodies were evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). Depressive, positive and negative symptoms were assessed, respectively, by the Calgary Depression Scale (CDS) and the Positive and Negative Syndrome Scale (PANSS). Cognitive performance was assessed in patients by the Brazilian version of the Schizophrenia Cognition Rating Scale (SCoRS-BR). Quality of life was assessed by the Brazilian version of the Quality of Life in Schizophrenia scale (QLS-BR). Results: The prevalence and titers of T. gondii IgM and IgG antibodies did not differ between patients and controls. The positive serology for T. gondii IgG antibodies was not associated with illness symptoms, cognitive performance, depressive symptoms or quality of life. Discussion: Our findings suggest that toxoplasmosis infection is not associated with severity of symptoms, quality of life, cognitive or depressive symptoms in schizophrenia patients.

show abstract

Section: Clinical Cognitive and Quality Of Life Assessmentsmentioning

confidence: 99%